Now Entering Russ's World
Ideasmench interviewed Jim Tananbaum, who is the CEO and founder of Foresite Capital. In the interview, he said that the Foresite Capital idea came from his two and a half decades of being an investment strategist and healthcare entrepreneur. During that time, he could point some experiences that led him to identify the key factors for success that could enable successful companies and entrepreneurs-most of which is lying in the science that’s behind innovation and also the teams that usually makes it all happen.
Jim Tananbaum continued saying that to him, Foresite means to harness and understand the future of healthcare. The insight came from realizing that due to innovative health care solutions usually need significantly more capital and time than most financiers and entrepreneurs appreciate.
According to Business Wire, Tananbaum said that to him, bringing his ideas to life involves capital and needs engaging the most persistent, effective and smartest thought health care leaders. The trend that excites him is that the science behind the innovation of healthcare is at the core heart of what he does and he’s consistently inspired by the ideas which the entrepreneurs could be applying in solving the largest unmet needs in healthcare.
The habit that makes him a more productive entrepreneur is that he has a focus on investment and business healthcare side. He is also academic at heart. He loves learning, so, this drives him in finding the brightest and the best solutions that offered by science. He has passion and unwavering commitment and persistence that helps him build the company and also expanding their innovative portfolio. Check out pelotontherapeutics.com for more details.
In a report by Insider Monkey, Tananbaum is the chief executive officer and founder of Foresite Capital. He piloted investments in 21 healthcare companies that are successful, including Jazz Pharmaceuticals, Amerigroup, and Amira Pharmaceuticals. Previously, Tananbaum held and founded management positions at Theravance and Gel Tex Pharmaceuticals.
Tananbaum studied at Harvard Medical School and earned his M.D. He went to Harvard Business School and received an M.B.A and a B.S.E.E. and BS from Yale University. He used to serve on the visiting committees and advisory boards in the HST program of Harvard and the engineering school at Yale University. You can search him on Google for more details.